Your browser doesn't support javascript.
Prone during pandemic: development and implementation of a quality-based protocol for proning severe COVID-19 hypoxic lung failure patients in situationally or historically low resource hospitals.
Astua, Alfredo J; Michaels, Eli K; Michaels, Andrew J.
  • Astua AJ; Division of Pulmonary and Critical Care Medicine, NYCHHC/Elmhurst Hospital Center, New York City, USA.
  • Michaels EK; Division of Epidemiology, University of California, Berkeley School of Public Health, Berkeley, CA, USA.
  • Michaels AJ; Division of Pulmonary and Critical Care Medicine, NYCHHC/Elmhurst Hospital Center, New York City, USA. andrewjmichaels@gmail.com.
BMC Pulm Med ; 21(1): 25, 2021 Jan 12.
Artículo en Inglés | MEDLINE | ID: covidwho-1024364
ABSTRACT

BACKGROUND:

Intermittent Prone Positioning (IPP) for Acute Respiratory Distress Syndrome (ARDS) decreases mortality. We present a program for IPP using expedient materials for settings of significant limitations in both overwhelmed established ICUs and particularly in low- and middle-income countries (LMICs) treating ARDS due to COVID-19 caused by SARS CoV-2.

METHODS:

The proning program evolved based on the principles of High Reliability Organizations (HROs) and Crew Resource Management (CRM). Patients with severe ARDS [PaO2FiO2 ratio (PFr) ≤ 150 on FiO2 ≥ 0.6 and PEEP ≥ 5 cm H2O] received IPP. Patients were placed prone 16 h each day. When PFr was ≥ 200 for > 8 h supine IPP ceased. IPP used available materials without requiring additional work from the bedside team. Changes in PFr, PaCO2, and the SaO2FiO2 ratio (SaFr) positionally were evaluated using t-statistics and ANOVA with Bonferroni correction (p < 0.017).

RESULTS:

Between 14APR2020 and 09MAY2020, at the peak of deaths in New York, there were 202 IPPs in 29 patients. Patients were 58.5 ± 1.7 years of age (37, 73), 76% male and had a body mass index (BMI) of 27.8 ± 0.8 (21, 38). Pressor agents were used in 76% and 17% received dialysis. The PFr prior to IPP was 107.5 ± 5.6 and 1 h after IPP was 155.7 ± 11.2 (p < 0.001 compared to pre-prone). PFr after the patients were placed supine was 131.5 ± 9.1 (p = 0.02). Pre-prone PaCO2 was 60.0 ± 2.5 and the 1-h post-prone PaCO2 was 67.2 ± 3.1 (p = 0.02). Supine PaCO2 after IPP was 60.4 ± 3.4 (p = 0.90). The SaFr prior to IPP was 121.3 ± 4.2 and the SaFr 1 h after positioning was 131.5 ± 5.1 (p = 0.03). The post-IPP supine SaFr was 139.7 ± 5.9 (p < 0.001). With ANOVA and Bonferroni correction there were statistically significant changes in PFr (p < 0.001) and SaFr (p < 0.001) and no significant changes in PaCO2 over the four time points measured. Using regression coefficients, the SaFrs predicted by PFrs of 150 and 200 at baseline are 133.2 and 147.3, respectively.

CONCLUSIONS:

An IPP program for patients with COVID-19 ARDS can be instituted rapidly, safely, and effectively during an overwhelming mass casualty scenario. This approach may be equally applicable in both traditionally austere environments in LMICs and in otherwise capable centers facing situational resource limitations.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Insuficiencia Respiratoria / Posicionamiento del Paciente / COVID-19 / Hipoxia Tipo de estudio: Estudio de cohorte / Estudio experimental / Estudio observacional / Estudio pronóstico Tópicos: Covid persistente Límite: Adulto / Anciano / Femenino / Humanos / Masculino / Middle aged Idioma: Inglés Revista: BMC Pulm Med Año: 2021 Tipo del documento: Artículo País de afiliación: S12890-021-01401-0

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Insuficiencia Respiratoria / Posicionamiento del Paciente / COVID-19 / Hipoxia Tipo de estudio: Estudio de cohorte / Estudio experimental / Estudio observacional / Estudio pronóstico Tópicos: Covid persistente Límite: Adulto / Anciano / Femenino / Humanos / Masculino / Middle aged Idioma: Inglés Revista: BMC Pulm Med Año: 2021 Tipo del documento: Artículo País de afiliación: S12890-021-01401-0